Home > Insider Trading > Tempest Therapeutics Inc. > Profile

Tempest Therapeutics Inc. (TPST)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

R Stephen Brady, President And Ceo, 2024-01-05
Samuel Whiting, Chief Medical Officer, 2024-01-05
Justin Trojanowski, Principal Accounting Officer, 2024-01-05

R Stephen Brady, President And Ceo, 2024-01-05
Samuel Whiting, Chief Medical Officer, 2024-01-05
Justin Trojanowski, Principal Accounting Officer, 2024-01-05
Nicholas Maestas, Vp Of Strategy And Finance, 2024-01-05
Michael Raab, Director, 2023-06-20
Geoffrey Nichol, Director, 2023-06-20
A Christine Pellizzari, Director, 2023-06-20
Ronit Simantov, Director, 2023-06-20
W. Thomas Dubensky, President, 2023-01-06
Pierre Lorenzo, Corporate Controller, 2022-06-22
Thomas Woiwode, Director, 2022-06-22
Versant Vantage Ii Gp, L.p., Large Shareholder, 2022-05-03
Versant Vantage Ii Gp-Gp, Llc, Large Shareholder, 2022-05-03
Versant Vantage Ii, L.p., Large Shareholder, 2022-05-03
Versant Ventures Vi Gp, L.p., Large Shareholder, 2022-05-03
Versant Ventures Vi Gp-Gp, Llc, Large Shareholder, 2022-05-03
Versant Venture Capital Vi, L.p., Large Shareholder, 2022-05-03
Versant Side Fund Iv, L.p., Large Shareholder, 2022-05-03
Versant Venture Capital Iv, L.p., Large Shareholder, 2022-05-03
Versant Ventures Iv, Llc, Large Shareholder, 2022-05-03
Rock Springs Capital Management Lp, Large Shareholder, 2022-01-10
Rock Springs Capital Master Fund Lp, Large Shareholder, 2022-01-10
Rock Springs Capital Llc, Large Shareholder, 2022-01-10
Stella Xu, Director, 2021-09-21
C. Julia Owens, Executive Chair, 2021-03-19
Lynn Jennifer Minai-Azary, Chief Financial Officer, 2021-03-02
J Louis Iii Arcudi, President And Ceo, 2021-03-02
Carole Nuechterlein, Director, 2020-06-23
Md P John Howe, Director, 2020-06-23
Giltner Carol Gallagher, Director, 2020-06-23
Lynne Mary Hedley, Director, 2020-06-23
J Habib Dable, Director, 2020-06-23
M. James Hindman, Director, 2020-06-23
Ryan Zeidan, Chief Development Officer, 2020-05-28
L Tamara Joseph, General Counsel And Secretary, 2020-05-28
Christophe Arbet-Engels, Chief Medical Officer, 2020-05-28
W Randall Whitcomb, Director, 2019-06-21
Pharis Mohideen, Chief Medical Officer, 2019-01-17
M. Jeffery Brinza, Sec., Cao And General Counsel, 2019-01-17
Woodruff James Lillie, Chief Scientific Officer, 2018-12-12
A. Christopher Kroeger, Chief Executive Officer, 2018-12-12
D Marc Kozin, Director, 2018-12-12
Jonathan Gillis, Senior Vice President, Finance, 2018-12-12
Mary Fisher, Director, 2018-12-12
Richard Aldrich, Director, 2018-12-12
W. Peter Sonsini, Large Shareholder, 2018-12-12
D Scott Sandell, Large Shareholder, 2018-12-12
M David Mott, Large Shareholder, 2018-12-12
Joshua Makower, Large Shareholder, 2018-12-12
Mohamad Makhzoumi, Large Shareholder, 2018-12-12
Jr. A. Anthony Florence, Large Shareholder, 2018-12-12
Forest Baskett, Large Shareholder, 2018-12-12
J Peter Barris, Large Shareholder, 2018-12-12
Nea 15 Gp, Llc, Large Shareholder, 2018-12-12
Nea Partners 15, L.p., Large Shareholder, 2018-12-12
New Enterprise Associates 15, L.p., Large Shareholder, 2018-12-12
Frazier Healthcare Vi, L.p., Large Shareholder, 2018-12-12
Fhm Vi, L.l.c., Large Shareholder, 2018-12-12
Fhm Vi, L.p., Large Shareholder, 2018-12-12
John Sexton, Director, 2018-07-06
D Jeffrey Capello, Director, 2018-07-06
Thomas Malley, Director, 2017-07-05
Michelle Dipp, Executive Chair, 2017-06-24
Christophe Couturier, Chief Financial Officer, 2017-03-14
W.d. Paul Chapman, Chief Operating Officer, 2016-05-12
F. Harald Stock, Director, 2016-01-07
Arthur Tzianabos, President And Cso, 2015-12-07
E Jeffrey Young, Chief Financial Officer, 2015-12-07
David Harding, Chief Commercial Officer, 2015-04-14
Theresa Mcneely, Evp, Chief Comm. Officer, 2015-04-09
Longwood Fund, L.p., Large Shareholder, 2015-01-16
Stephen Kraus, Director, 2014-06-17
Deer Management Co. Llc, Large Shareholder, Director, 2014-06-17
H Christoph Westphal, Large Shareholder, Director, 2014-03-11
A Christopher Bleck, Chief Commercial Officer, 2013-09-12
L Jonathan Tilly, Director, 2013-06-11
Frances Alison Lawton, Chief Operating Officer, 2013-06-11
M Christopher Lindblom, Vice President Of Finance, 2013-06-11
General Catalyst Gp V, Llc, Large Shareholder, Director, 2012-08-15
E Joel Cutler, Large Shareholder, Director, 2012-08-15
P David Fialkow, Large Shareholder, Director, 2012-08-15
General Catalyst Group V Lp, Large Shareholder, Director, 2012-08-15
J David Orfao, Large Shareholder, Director, 2012-08-15
Gc Entrepreneurs Fund V, Lp, Large Shareholder, Director, 2012-08-15
General Catalyst Partners V, L.p., Large Shareholder, Director, 2012-08-15
G John Simon, Director, 2012-08-15
Deer Vii & Co. L.p., Large Shareholder, Director, 2012-08-14
Deer Vii & Co. Ltd., Large Shareholder, Director, 2012-08-14
L.p. Vii Partners Venture Bessemer, Large Shareholder, Director, 2012-08-14
Bvp Vii Special Opportunity Fund Lp, Large Shareholder, Director, 2012-08-14
L.p. Institutional Vii Partners Venture Bessemer, Large Shareholder, Director, 2012-08-14
C Scott Chappel, Vp And Cso, 2012-06-11

Show All Insiders (92)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on March 06, 2019, 10:18 am based on SEC 13F filings Last update: March 06, 2019, 10:18 am

No.	Hedge Fund	Value	Activity	% Port
1.	Point72 Asset Management Steve Cohen	$0	-100%	0%
2.	Two Sigma Advisors John Overdeck And David Siegel	$0	-100%	0%
3.	Prosight Capital Lawrence Hawkins	$0	-100%	0%
4.	Sabby Capital Hal Mintz	$0	-100%	0%
5.	GMT Capital Thomas E. Claugus	$0	-100%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Woiwode	$2.36	2,118,644	Large Shareholder, Director	2,118,644	2022-04-29	Filing
Dubensky	$4.78	2,000	Officer, Director	113,343	2022-01-07	Filing
Whiting	$4.80	1,700	Officer	1,901	2022-01-06	Filing
Aldrich	$7.00	425,000	Director	962,056	2016-06-01	Filing
Dipp	$7.00	425,000	Officer, Director	962,056	2016-06-01	Filing